1.Clinical value of combined detection of serum CA724, CEA and TNF-α for advanced gastric cancer
Zonglin LI ; Huaiwu JIANG ; Dong XIA ; Qing LIU ; Tuping GONG
Journal of Chinese Physician 2015;17(7):992-994
Objective To explore the clinical value of combined detection of serum carbohydrate antigen 724 (CA724),carcinoembryonic antigen (CEA),and tumor necrosis factor-α (TNF-α) for the diagnosis,assessment of curative effect,and illness monitoring for advanced gastric cancer (AGC).Methods Serum levels of CA724,CEA and TNF-α were measured by the methods of chemiluminescence and compared in 20 patients with AGC (Group A),20 patients with benign gastric disease (Group B),and 20 healthy adults (Group C).Also,serum levels of CA724,CEA and TNF-α in peripheral blood as well as in portal vein were measured and compared before and after surgical treatment in patients of group A.Results The serum levels of CA724,CEA and TNF-α in patients of group A were significantly higher than groups B and C (P < 0.05).In addition,the serum levels of CA724,CEA and TNF-α in patients of group A were decreased after surgical treatment and increased slightly after one month (P < 0.05).Conclusions The serum levels of CA724,CEA and TNF-α in most patients of AGC are significantly elevated and the combined detection of serum CA724,CEA and TNF-α contributes to the diagnosis,assessment of curative effect,and illness monitoring for AGC.
2. Clinicopatholigical differences between patients with adenocarcinoma of esophagogastric junction and gastric cancer without esophagogastric junction invasion
Run XU ; Jian LI ; Dengmin HU ; Tuping GONG ; Yao ZHANG
International Journal of Surgery 2019;46(12):830-834
Objective:
To investigate the clinicopatholigical differences between patients with adenocarcinoma of esophagogastric junction (AEG) and gastric cancer without esophagogastric junction invasion, and relationship between the two type cancers and Helicobacter pylori (Hp) infection, body mass index.
Methods:
A retrospective analysis was performed on 577 cases of gastric cancer patientsin the Third Hospital of Mianyang from December 2013 to February 2018.Patients were divided into AEG group (